Video of the panel discussion “Reproductive Rights around the Globe,” held at Harvard Law School on November 7, is now available via the Petrie-Flom Center’s website. The panel — cosponsored by the Petrie-Flom Center; the Human Rights Program; and the Child Advocacy Program at Harvard Law School; and the Harvard Global Health Institute — included legal experts on a variety…
In a new piece at the Huffington Post, Bill of Health Contributor Dov Fox explores “The Forgotten Holding of Roe v. Wade“ — that states have a valid reason to regulate reproductive conduct because of an interest in “potential life.” That “the State may [legitimately] assert” that interest, Roe held, “as long as at leastpotential life is involved,” explains…
For more information, please visit our website.
For more information, please visit our website.
The Petrie-Flom Center and Harvard Law School are delighted to announce our partnership with Duke University, Stanford University, and Oxford University Press to launch a new peer-reviewed, open access, online journal in 2014: Journal of Law and the Biosciences (JLB). JLB will become the preeminent outlet to publish cutting-edge scholarship wherever law and the biosciences intersect. The journal…
For more information, please visit our website.
Call for Papers: Intersections in Reproduction: Perspectives on Abortion, Assisted Reproductive Technologies, and Judicial Review Abortion and reproductive technologies have historically occupied separate realms in law, policy, and academia. In spite of some obvious and natural overlap, scholarship exploring the relationship between abortion and assisted reproduction is sparse. In 2014, Judith Daar (Whittier Law School) and…
In “Company seeks to make sperm banks safer,” a recent article in the Boston Globe, Bill of Health blogger Dov Fox recently weighed in on new companies that propose to screen sperm donor DNA in an effort to reduce the chance that children conceived with donated sperm will have childhood genetic diseases: Dov Fox, an assistant…
In the first installment of our new collaboration with Genetics in Medicine, we are highlighting an article released yesterday discussing 23andMe’s controversial “designer baby” patent, which has already gotten quite a bit of attention. Here’s the press release, and an exclusive commentary from Sigrid Sterckx, one of the article’s authors, can be found in a…
[Posted on behalf of Sigrid Sterckx, as part of our collaboration with Genetics in Medicine] Yesterday, 3 October, an article I wrote with three co-authors about a controversial US patent was published by the (Nature) journal Genetics in Medicine. The patent, granted last week to the Californian Direct-To-Consumer genetic testing company 23andMe, is entitled ‘Gamete donor…
